Trobix Bio

Netanya, Israel

Trobix Bio is a company that develops and commercializes antibacterial products.

$3.0M raised

Mar 2023

Series A

Top Investors

Chartered Opus

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Trobix Bio raised?

Trobix Bio has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.

Who are Trobix Bio's investors?

Trobix Bio's investors include Chartered Opus.

Where is Trobix Bio headquartered?

Trobix Bio is headquartered in Netanya, Israel.

What does Trobix Bio do?

Trobix Bio is a company that develops and commercializes antibacterial products.

What stage is Trobix Bio at?

Trobix Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 30, 2023.

MLA

"Trobix Bio — Funding & Investors." VCBacked, March 30, 2023, https://www.vcbacked.co/company/trobix-bio. Accessed June 17, 2026.

APA

VCBacked. (2023). Trobix Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/trobix-bio

Wikipedia (cite web)

{{cite web |title=Trobix Bio — Funding & Investors |url=https://www.vcbacked.co/company/trobix-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 30, 2023.